Merck & Co Inc
Change company Symbol lookup
Select an option...
MRK Merck & Co Inc
EVK Ever-Glory International Group Inc
TGODF Green Organic Dutchman Holdings Ltd
AVNI Arvana Inc
ARCC Ares Capital Corp
BCDA BioCardia Inc
AFG American Financial Group Inc
MGEN miRagen Therapeutics Inc
CVLG Covenant Logistics Group Inc
ARLO Arlo Technologies Inc
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Postmarket

Last Trade
Delayed
$0.00
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$81.56
Day's Change
1.17 (1.46%)
Bid
--
Ask
--
B/A Size
--
Day's High
82.46
Day's Low
80.82
Volume
(Average)
Volume:
7,810,867

10-day average volume:
8,740,996
7,810,867

MRK's position in the Pharmaceuticals industry

Industry PeersMRKJNJZTSELANRETA

Summary

Company ProfileMerck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through...
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments...
Go to JNJ summary
Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has...
Go to ZTS summary
Elanco Animal Health Incorporated is an animal health company that develops, manufactures and markets products for companion and food animals. The Company offers its products under four primary...
Go to ELAN summary
Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing product candidates that modulate the activity of...
Go to RETA summary
52-Week Change

VS. INDUSTRY
-7.79%
5.23%
33.07%
10.39%
-21.72%
Market Cap

VS. INDUSTRY
$202.0B
$379.1B
$76.7B
$14.8B
$5.3B
Beta

VS. INDUSTRY
0.4
0.7
0.7
--
1.7
Dividend Yield

VS. INDUSTRY
3.26%
2.81%
0.50%
--
--
P/E (TTM, GAAP)

VS. INDUSTRY
17.56x
23.04x
46.36x
--
--
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$47.3B
$80.9B
$6.5B
$2.9B
$8.5M
Profit Margin

VS. INDUSTRY
24.47%
20.64%
25.41%
-8.45%
-4,341.23%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
-1.06%
-0.24%
21.80%
-16.91%
--
Revenue Growth (TTM)

VS. INDUSTRY
3.00%
-1.04%
6.37%
-5.28%
-73.69%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.